Literature DB >> 35124826

ACE inhibitors: The secret to prevent cirrhosis complications and HCC in NAFLD?

Mazen Noureddin1, Manal F Abdelmalek2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35124826     DOI： 10.1002/hep.32399

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.298


× No keyword cloud information.
  2 in total

1.  Hypertension is prevalent in non-alcoholic fatty liver disease and increases all-cause and cardiovascular mortality.

Authors:  Cheng Han Ng; Zhen Yu Wong; Nicholas W S Chew; Kai En Chan; Jieling Xiao; Nilofer Sayed; Wen Hui Lim; Darren Jun Hao Tan; Ryan Wai Keong Loke; Phoebe Wen Lin Tay; Jie Ning Yong; Gywneth Kong; Daniel Q Huang; Jiong-Wei Wang; Mark Chan; Mayank Dalakoti; Nobuharu Tamaki; Mazen Noureddin; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah
Journal:  Front Cardiovasc Med       Date:  2022-08-08

2.  Prognostic Factors for Overall Survival in Patients with HCV-Related HCC Undergoing Molecular Targeted Therapies: Beyond a Sustained Virological Response.

Authors:  Yasunori Minami; Tomoko Aoki; Hirokazu Chishina; Masahiro Takita; Satoru Hagiwara; Hiroshi Ida; Kazuomi Ueshima; Naoshi Nishida; Masatoshi Kudo
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.